These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24613464)

  • 1. Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
    Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN
    Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in novel drug delivery strategies for breast cancer therapy.
    Dhankhar R; Vyas SP; Jain AK; Arora S; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Oct; 38(5):230-49. PubMed ID: 20677900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.
    Ji T; Zhao Y; Ding Y; Nie G
    Adv Mater; 2013 Jul; 25(26):3508-25. PubMed ID: 23703805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
    Parhi P; Mohanty C; Sahoo SK
    Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD; Mayer LD
    Ther Deliv; 2014 Feb; 5(2):149-71. PubMed ID: 24483194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale delivery systems for multiple drug combinations in cancer.
    Cao Y; Wang B; Lou D; Wang Y; Hao S; Zhang L
    Future Oncol; 2011 Nov; 7(11):1347-57. PubMed ID: 22044207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered nanostructural materials for application in cancer biology and medicine.
    Mahmood M; Casciano D; Xu Y; Biris AS
    J Appl Toxicol; 2012 Jan; 32(1):10-9. PubMed ID: 21882206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New frontiers in nanotechnology for cancer treatment.
    Alexis F; Rhee JW; Richie JP; Radovic-Moreno AF; Langer R; Farokhzad OC
    Urol Oncol; 2008; 26(1):74-85. PubMed ID: 18190835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.